Molecular Neurodegeneration and Therapeutic Approaches
Wellcome Genome Campus, Hinxton, CB10 1RQ, UK
This event will provide an overview of the molecular basis of neurodegenerative disorders, and is aimed at individuals working in neurodegenerative research, neurogenetics or translational neuroscience.
The programme will cover several neurological disorders, including Huntington’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and various forms of dementia, including Alzheimer’s disease. Discussions will also highlight therapeutic approaches for combating neurodegeneration, bioinformatics techniques used in neurogenetics and experimental models for neurodegenerative disease.
Returning to the Wellcome Genome Campus, the programme will include popular aspects of our successful 2021 virtual event. This year’s combined format will comprise of a mixture of in-person and live-streamed lectures, live Q&A sessions, participant presentations and plenty of face-to-face networking opportunities with other attendees and experts in the field.
Wellcome Connecting Science
John Hardy – University College London, UK